Free Trial
The Rate Lock Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 a Year
Claim MarketBeat All Access Sale Promotion
OTCMKTS:TAIPY

Taisho Pharmaceutical (TAIPY) Stock Price, News & Analysis

Taisho Pharmaceutical logo
$14.00 0.00 (0.00%)
As of 10/29/2026

About Taisho Pharmaceutical Stock (OTCMKTS:TAIPY)

Advanced

Key Stats

Today's Range
$14.00
▼
$14.00
50-Day Range
$14.00
▼
$14.00
52-Week Range
$8.88
▼
$15.52
Volume
N/A
Average Volume
1,958 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Taisho Pharmaceutical Holdings Co., Ltd. is a Japanese healthcare company engaged in the development, manufacture and sale of prescription medicines and over-the-counter (OTC) products. Its consumer healthcare portfolio includes treatments for cold and flu symptoms, gastrointestinal conditions, hair growth, fatigue and other everyday health concerns, as well as health foods and related products.

The company’s brands include Pabron cold remedies, Lipovitan energy drinks, RiUP hair-growth products and Colac digestive medicines. Its prescription pharmaceutical business has focused on areas such as metabolic disorders, infectious diseases and other therapeutic categories, supported by research and development activities.

Taisho Pharmaceutical traces its origins to 1912 and is headquartered in Tokyo, Japan. In addition to serving the Japanese market, the company has developed international operations through subsidiaries, partnerships and product sales in parts of Asia and other overseas markets. Its business has historically combined consumer healthcare with prescription pharmaceuticals.

AI Generated. May Contain Errors.

Receive TAIPY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Taisho Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TAIPY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

TAIPY Stock Analysis - Frequently Asked Questions

Taisho Pharmaceutical's stock was trading at $14.00 at the start of the year. Since then, TAIPY shares have increased by 0.0% and is now trading at $14.00.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:TAIPY
CIK
1716957
Fax
N/A
Employees
8,784
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (OTCMKTS:TAIPY) was last updated on 10/29/2026 by MarketBeat.com Staff.
From Our Partners